Logo
Home
About
Subscribe
Upgrade
Search
Log In
Subscribe
Logo
Search

News Analysis

Corporate Strategy

+1

Samsung Biologics Launches $1.8 Billion All-Cash Bid for PolyPeptide in Peptide Manufacturing Push

Jul 20, 2026

•

2 min read

Samsung Biologics Launches $1.8 Billion All-Cash Bid for PolyPeptide in Peptide Manufacturing Push

The Korean CDMO giant's offer at a 40% premium to the undisturbed price targets Switzerland's leading peptide API manufacturer as demand for GLP-1 therapies reshapes the pharmaceutical supply chain.

News Analysis

+1

Segro Rejects Prologis's $18.2 Billion Takeover Bid as Put-Up-or-Shut-Up Deadline Looms

Jul 20, 2026

•

2 min read

Segro Rejects Prologis's $18.2 Billion Takeover Bid as Put-Up-or-Shut-Up Deadline Looms

The UK warehouse giant's board has now turned down three escalating all-share proposals from the world's largest logistics landlord, with a Takeover Panel deadline of 22 July forcing a decision.

Search